BridgeBio Pharma (BBIO) PT Raised to $110 at Mizuho
Mizuho analyst Salim Syed raised the price target on BridgeBio Pharma (NASDAQ: BBIO) to $110.00 (from $96.00) while maintaining a ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)